Fulcrum Equity Management’s Loncar China BioPharma ETF CHNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-9,126
| Closed | -$340K | – | 213 |
|
|
2021
Q3 | $340K | Sell |
9,126
-629
| -6% | -$23.4K | 0.13% | 118 |
|
|
2021
Q2 | $464K | Buy |
+9,755
| New | +$464K | 0.17% | 105 |
|
|
2021
Q1 | – | Sell |
-10,023
| Closed | -$326K | – | 215 |
|
|
2020
Q4 | $326K | Buy |
10,023
+519
| +5% | +$16.9K | 0.13% | 123 |
|
|
2020
Q3 | $292K | Buy |
+9,504
| New | +$292K | 0.14% | 113 |
|